Mitochondrial disease: Linda Hasadsri, M.D., Ph.D.

(00:32):

Before we get started, Dr. Hasadsri, could you provide us with a little bit about you and your background?

(02:43):
Can you differentiate a little bit between what we offer from a molecular standpoint, but what we offer from a biochemical genetic standpoint in terms of mitochondrial testing?

(06:25):
When you would utilize this mitochondrial testing and what kind of patient treatment is this kind of testing guide? How is this utilized in terms of the way the patient is treated?

(09:10):
How does the testing that Mayo clinic lab offers in terms of mitochondrial differ from what other labs are offering right now in the same area?

(13:33):
Is there anything you can think of that you would want to add to all of this or anything you think that we we've left out? I think you've been very comprehensive, but I just wanted to end with that and just see if there was anything else that you wanted to say?

Resources
GDF15 | Growth Differentiation Factor 15, Plasma

OAU | Organic Acids Screen, Urine

AAQP | Amino Acids, Quantitative, Plasma

TQ10 | Celiac Disease Serology Cascade, Serum

FAPM | Fatty Acid Profile, Mitochondrial (C8-C18), Serum

PYR/PYRC | CPyruvic Acid, Blood/ Pyruvate, Spinal Fluid

PDHC | Pyruvate Dehydrogenase Complex (PDHC), Fibroblasts

MITOP | Mitochondrial Full Genome Analysis by Next-Generation Sequencing (NGS), Varies

MITON | Mitochondrial Nuclear Gene Panel by Next-Generation Sequencing (NGS), Varies

MITOT | Combined Mitochondrial Analysis, Mitochondrial Full Genome and Nuclear Gene Panel, Varies